Sinofn Health Sinofn Health

OEM Dietary Supplement Makers: Manufacturers & Factories

Engineering Bioavailability & Innovation: SINOFN Health's Global Contract Manufacturing Ecosystem for Nutraceutical Brands.

Featured Manufacturing Capabilities

The Global Nutraceutical Manufacturing Landscape

The dietary supplement industry has shifted from volume-driven production to precision manufacturing. As an OEM expert, SINOFN Health recognizes that global brands no longer seek just "factories"; they seek "innovation partners." The modern consumer demands transparency, clinical efficacy, and sustainable sourcing. Our industrial strategy is built upon the synthesis of Chinese Academy of Sciences R&D and industrial-scale execution, ensuring that we bridge the gap between laboratory-grade discovery and consumer-ready health solutions.

53,000㎡Facility Footprint
350M+Capital Assets
25+Patent Portfolio
71+Global Trademarks
🔬

Science-Driven R&D

Founded in 2012, backed by CAS. Our R&D center in Tianjin leads advancements in metabolic disorders and functional food design.

🏗️

Advanced Factory Tour

10+ dedicated lines for softgels, gummies, and powders. ISO 22000, HACCP, FSSC 22000 certified with 500M+ annual capacity.

🌍

Global OEM Solutions

Shanghai-based trading hub bridging high-quality Chinese manufacturing with the rigorous standards of global markets.

Industry Trends & Future Roadmap

Personalized Nutrition & Bioavailability

The "one-size-fits-all" model is obsolete. At SINOFN, we focus on micronutrient delivery systems. From oral liquid solutions to controlled-release tablets, our R&D team led by CAS-affiliated experts ensures maximum absorption and clinical results. We are scaling production of bioactive compounds (like Tremella polysaccharides and cAMP) that are shaping the future of longevity supplements.

Sustainability & Clean Label

Global regulation is tightening. Our manufacturing roadmap includes sustainable sourcing protocols and "clean label" formulations, removing unnecessary additives to meet the clean-eating requirements of European and North American markets.

Expertise & Leadership

Dr. Tan Shengjie

Medical Innovation Director, Ph.D Peking University. 15+ years of metabolic disorder formulation expertise.

Dr. Zhang Ying

R&D Lead, CAS Postdoc. Specializing in advanced bioactive delivery systems.

Hans van Dijk

Formulation Director, Netherlands Expert. Bridging EU regulatory compliance with Asian manufacturing scale.

Frequently Asked Questions

How does SINOFN ensure quality control in mass production?

We utilize comprehensive HPLC/GC-MS contaminant screening, microbiological safety testing, and rigorous stability validation to ensure every batch meets international standards.

Can you handle small-batch prototypes or startups?

Yes. Our R&D center provides pilot-scale prototyping, allowing startups and new brands to test formulations before full-scale commercialization.

What are your primary certification credentials?

We hold certifications for ISO9001, ISO22000, HACCP, and HALAL, supported by a portfolio of 36 patents and 71 trademarks.

Core Product Portfolio